Booster immunization improves the generation of T follicular helper (Tfh) cells specific to hepatitis B surface antigen (HBsAg) after prenatal HBsAg exposure. Issue 39 (15th September 2021)
- Record Type:
- Journal Article
- Title:
- Booster immunization improves the generation of T follicular helper (Tfh) cells specific to hepatitis B surface antigen (HBsAg) after prenatal HBsAg exposure. Issue 39 (15th September 2021)
- Main Title:
- Booster immunization improves the generation of T follicular helper (Tfh) cells specific to hepatitis B surface antigen (HBsAg) after prenatal HBsAg exposure
- Authors:
- Wang, Ruijun
Chen, Kun
Wang, Yuting
Liu, Chang
Wu, Zhiyuan
Wang, Dongmei
Qu, Chunfeng - Abstract:
- Abstract: Breakthrough infections of hepatitis B virus (HBV) after neonatal vaccination occurred in some adolescents and young adults who were born to mothers with hepatitis B surface antigen (HBsAg). We aimed to determine the impacts of prenatal HBsAg exposure on the generation of T follicular helper (Tfh) cells and antibodies (anti-HBs) specific to HBsAg. To mimic human prenatal HBsAg exposure, we mated female Alb1-HBV (HBV-M) mice with male C57BL/6J mice. Of their first filial generation (F1), HBV-M/F1 + expressed HBsAg in liver tissues and blood, and HBV-M/F1 − mice exposed HBsAg in amniotic fluid. At their four weeks old, each HBV-M/F1 mouse was immunized with hepatitis B vaccine containing 5 μg HBsAg subcutaneously. Both HBV-M/F1 − and HBV-M/F1 + mice had reduced generation of HBsAg-specific CD4 + CXCR5 + PD1 + Tfh cells and CD138 + IgD − plasma cells in comparison with C57BL/6J mice. Results of coculturing the Tfh cells with B cells that were isolated from different strains of mice indicated that CD4 + T cell activation in response to HBsAg was critical for anti-HBs generation after prenatal HBsAg exposure. When interleukin (IL) 21 was supplemented, the generation of HBsAg-specific Tfh and plasma cells in HBV-M/F1 − mice was improved, while supplementation showed little effect in HBV-M/F1 + mice. In HBV-M/F1 − mice, HBV vaccine booster improved the generation of Tfh cells and plasma cells, and enhanced anti-HBs production. Conclusion: Impaired generation ofAbstract: Breakthrough infections of hepatitis B virus (HBV) after neonatal vaccination occurred in some adolescents and young adults who were born to mothers with hepatitis B surface antigen (HBsAg). We aimed to determine the impacts of prenatal HBsAg exposure on the generation of T follicular helper (Tfh) cells and antibodies (anti-HBs) specific to HBsAg. To mimic human prenatal HBsAg exposure, we mated female Alb1-HBV (HBV-M) mice with male C57BL/6J mice. Of their first filial generation (F1), HBV-M/F1 + expressed HBsAg in liver tissues and blood, and HBV-M/F1 − mice exposed HBsAg in amniotic fluid. At their four weeks old, each HBV-M/F1 mouse was immunized with hepatitis B vaccine containing 5 μg HBsAg subcutaneously. Both HBV-M/F1 − and HBV-M/F1 + mice had reduced generation of HBsAg-specific CD4 + CXCR5 + PD1 + Tfh cells and CD138 + IgD − plasma cells in comparison with C57BL/6J mice. Results of coculturing the Tfh cells with B cells that were isolated from different strains of mice indicated that CD4 + T cell activation in response to HBsAg was critical for anti-HBs generation after prenatal HBsAg exposure. When interleukin (IL) 21 was supplemented, the generation of HBsAg-specific Tfh and plasma cells in HBV-M/F1 − mice was improved, while supplementation showed little effect in HBV-M/F1 + mice. In HBV-M/F1 − mice, HBV vaccine booster improved the generation of Tfh cells and plasma cells, and enhanced anti-HBs production. Conclusion: Impaired generation of HBsAg-specific Tfh cells and plasma cells after prenatal HBsAg exposure can be improved by HBV vaccine booster, most likely increasing IL-21 production. … (more)
- Is Part Of:
- Vaccine. Volume 39:Issue 39(2021)
- Journal:
- Vaccine
- Issue:
- Volume 39:Issue 39(2021)
- Issue Display:
- Volume 39, Issue 39 (2021)
- Year:
- 2021
- Volume:
- 39
- Issue:
- 39
- Issue Sort Value:
- 2021-0039-0039-0000
- Page Start:
- 5571
- Page End:
- 5579
- Publication Date:
- 2021-09-15
- Subjects:
- T follicular helper cells -- Antibodies against hepatitis B surface antigens -- Prenatal exposure -- Interleukin 21 -- Vaccine booster
HBV Hepatitis B virus -- HBsAg Hepatitis B surface antigen -- Anti-HBs Antibodies against hepatitis B surface antigen -- Tfh cell T follicular helper cell -- CXCR5 CXC chemokine receptor 5 -- PD-1 Programmed cell death protein 1 -- IL Interleukin -- IFNγ Interferon gamma -- Tbx21 T-box transcription factor 21 -- Gata3 GATA binding protein 3 -- Bcl6 B cell lymphoma 6 -- Gapdh Glyceraldehyde 3-phosphate dehydrogenase -- Anti-M1 Antibodies against influenza A H1N1 virus matrix protein 1 -- ASCs Antibody secreting cells
Vaccines -- Periodicals
615.372 - Journal URLs:
- http://www.sciencedirect.com/science/journal/0264410X ↗
http://www.clinicalkey.com/dura/browse/journalIssue/0264410X ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/0264410X ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.vaccine.2021.08.020 ↗
- Languages:
- English
- ISSNs:
- 0264-410X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 9138.628000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 19076.xml